0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GMP Cytokines Market Research Report 2026
Published Date: 2026-02-27
|
Report Code: QYRE-Auto-7X9215
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global GMP Cytokines Market Outlook 2022
BUY CHAPTERS

Global GMP Cytokines Market Research Report 2026

Code: QYRE-Auto-7X9215
Report
2026-02-27
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

GMP Cytokines Market Size

The global GMP Cytokines market was valued at US$ 160 million in 2025 and is anticipated to reach US$ 280 million by 2032, at a CAGR of 8.4% from 2026 to 2032.

GMP Cytokines Market

GMP Cytokines Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on GMP Cytokines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well. GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.
Drivers:
Increasing demand for cell and gene therapies: The rise of cell-based and gene therapies, such as CAR-T therapies and regenerative medicine, has significantly increased the demand for high-quality, GMP (Good Manufacturing Practice) cytokines. Cytokines play a crucial role in cell expansion and differentiation, making them essential in the manufacturing process of these therapies.
Growth in biopharmaceutical R&D: The pharmaceutical industry's focus on developing innovative biologics, cancer immunotherapies, and personalized medicine has led to a surge in demand for GMP-grade cytokines. These are critical for ensuring the consistency, safety, and effectiveness of drug development and clinical trials.
Advances in stem cell research: The expansion of stem cell research, which requires high-quality cytokines for the differentiation and proliferation of stem cells, has further driven the demand for GMP-grade cytokines in both academic and industrial research settings.
Regulatory requirements: The need for compliance with regulatory standards, especially in clinical trials and drug manufacturing, has heightened the demand for GMP-certified cytokines. These stringent standards ensure that cytokines used in clinical and therapeutic applications are of the highest purity and quality.
Rising interest in cancer immunotherapy: Cytokines are essential components in cancer immunotherapies, which harness the body’s immune system to fight cancer. As immunotherapy research grows, so does the demand for GMP cytokines, particularly in the production of therapies targeting immune modulation.
Challenges:
High production costs: Producing GMP-grade cytokines involves stringent quality controls and highly specialized manufacturing processes, which significantly increase production costs. This makes GMP cytokines expensive, limiting their accessibility, especially for smaller research institutions and companies.
Complexity of manufacturing: The production of GMP cytokines requires sophisticated technologies, including recombinant protein production, purification, and quality control processes, which can be complex and time-consuming. Any deviation in these processes can lead to batch failures, affecting supply chain stability.
Regulatory hurdles: Obtaining regulatory approvals for GMP cytokines used in clinical applications can be a lengthy and challenging process. Manufacturers must meet stringent quality and safety standards, which can delay the availability of new products and limit market growth.
Supply chain issues: The production of GMP cytokines is highly dependent on reliable and consistent raw material supplies. Any disruptions in the supply chain, such as shortages of critical raw materials, can impact production timelines and availability, posing a challenge to manufacturers.
Competition from alternative technologies: As new technologies emerge in the biopharmaceutical industry, such as synthetic biology and non-cytokine-based methods for cell growth and differentiation, the demand for traditional cytokines could be threatened, impacting market growth in the long term.
This report delivers a comprehensive overview of the global GMP Cytokines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding GMP Cytokines. The GMP Cytokines market size, estimates, and forecasts are provided in terms of sales volume (mg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global GMP Cytokines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist GMP Cytokines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of GMP Cytokines Market Report

Report Metric Details
Report Name GMP Cytokines Market
Accounted market size in 2025 US$ 160 million
Forecasted market size in 2032 US$ 280 million
CAGR 8.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • TNF
  • Interleukin
  • Growth Factor
  • Others
by Application
  • Cell/Gene Therapy
  • Tissue-Engineered Products
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bio-Techne, PeproTech, CellGenix, Miltenyi Biotec, Cytiva, Lonza, ReproCELL, Sino Biological, Akron Biotech, Creative Bioarray
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for GMP Cytokines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines GMP Cytokines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is GMP Cytokines Market growing?

Ans: The GMP Cytokines Market witnessing a CAGR of 8.4% during the forecast period 2026-2032.

What is the GMP Cytokines Market size in 2032?

Ans: The GMP Cytokines Market size in 2032 will be US$ 280 million.

Who are the main players in the GMP Cytokines Market report?

Ans: The main players in the GMP Cytokines Market are Bio-Techne, PeproTech, CellGenix, Miltenyi Biotec, Cytiva, Lonza, ReproCELL, Sino Biological, Akron Biotech, Creative Bioarray

What are the Application segmentation covered in the GMP Cytokines Market report?

Ans: The Applications covered in the GMP Cytokines Market report are Cell/Gene Therapy, Tissue-Engineered Products, Others

What are the Type segmentation covered in the GMP Cytokines Market report?

Ans: The Types covered in the GMP Cytokines Market report are TNF, Interleukin, Growth Factor, Others

1 GMP Cytokines Market Overview
1.1 Product Definition
1.2 GMP Cytokines by Type
1.2.1 Global GMP Cytokines Market Value by Type: 2025 vs 2032
1.2.2 TNF
1.2.3 Interleukin
1.2.4 Growth Factor
1.2.5 Others
1.3 GMP Cytokines by Application
1.3.1 Global GMP Cytokines Market Value by Application: 2025 vs 2032
1.3.2 Cell/Gene Therapy
1.3.3 Tissue-Engineered Products
1.3.4 Others
1.4 Global GMP Cytokines Market Size Estimates and Forecasts
1.4.1 Global GMP Cytokines Revenue 2021–2032
1.4.2 Global GMP Cytokines Sales 2021–2032
1.4.3 Global GMP Cytokines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 GMP Cytokines Market Competition by Manufacturers
2.1 Global GMP Cytokines Sales Market Share by Manufacturers (2021–2026)
2.2 Global GMP Cytokines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global GMP Cytokines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of GMP Cytokines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of GMP Cytokines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of GMP Cytokines, Product Types and Applications
2.7 Global Key Manufacturers of GMP Cytokines, Date of Entry into the Industry
2.8 Global GMP Cytokines Market Competitive Situation and Trends
2.8.1 Global GMP Cytokines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global GMP Cytokines Players Market Share by Revenue
2.8.3 Global GMP Cytokines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GMP Cytokines Market Scenario by Region
3.1 Global GMP Cytokines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global GMP Cytokines Sales by Region: 2021–2032
3.2.1 Global GMP Cytokines Sales by Region: 2021–2026
3.2.2 Global GMP Cytokines Sales by Region: 2027–2032
3.3 Global GMP Cytokines Revenue by Region: 2021–2032
3.3.1 Global GMP Cytokines Revenue by Region: 2021–2026
3.3.2 Global GMP Cytokines Revenue by Region: 2027–2032
3.4 North America GMP Cytokines Market Facts & Figures by Country
3.4.1 North America GMP Cytokines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America GMP Cytokines Sales by Country (2021–2032)
3.4.3 North America GMP Cytokines Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe GMP Cytokines Market Facts & Figures by Country
3.5.1 Europe GMP Cytokines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe GMP Cytokines Sales by Country (2021–2032)
3.5.3 Europe GMP Cytokines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GMP Cytokines Market Facts & Figures by Region
3.6.1 Asia Pacific GMP Cytokines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific GMP Cytokines Sales by Region (2021–2032)
3.6.3 Asia Pacific GMP Cytokines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America GMP Cytokines Market Facts & Figures by Country
3.7.1 Latin America GMP Cytokines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America GMP Cytokines Sales by Country (2021–2032)
3.7.3 Latin America GMP Cytokines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa GMP Cytokines Market Facts & Figures by Country
3.8.1 Middle East and Africa GMP Cytokines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa GMP Cytokines Sales by Country (2021–2032)
3.8.3 Middle East and Africa GMP Cytokines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GMP Cytokines Sales by Type (2021–2032)
4.1.1 Global GMP Cytokines Sales by Type (2021–2026)
4.1.2 Global GMP Cytokines Sales by Type (2027–2032)
4.1.3 Global GMP Cytokines Sales Market Share by Type (2021–2032)
4.2 Global GMP Cytokines Revenue by Type (2021–2032)
4.2.1 Global GMP Cytokines Revenue by Type (2021–2026)
4.2.2 Global GMP Cytokines Revenue by Type (2027–2032)
4.2.3 Global GMP Cytokines Revenue Market Share by Type (2021–2032)
4.3 Global GMP Cytokines Price by Type (2021–2032)
5 Segment by Application
5.1 Global GMP Cytokines Sales by Application (2021–2032)
5.1.1 Global GMP Cytokines Sales by Application (2021–2026)
5.1.2 Global GMP Cytokines Sales by Application (2027–2032)
5.1.3 Global GMP Cytokines Sales Market Share by Application (2021–2032)
5.2 Global GMP Cytokines Revenue by Application (2021–2032)
5.2.1 Global GMP Cytokines Revenue by Application (2021–2026)
5.2.2 Global GMP Cytokines Revenue by Application (2027–2032)
5.2.3 Global GMP Cytokines Revenue Market Share by Application (2021–2032)
5.3 Global GMP Cytokines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bio-Techne
6.1.1 Bio-Techne Company Information
6.1.2 Bio-Techne Description and Business Overview
6.1.3 Bio-Techne GMP Cytokines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bio-Techne GMP Cytokines Product Portfolio
6.1.5 Bio-Techne Recent Developments/Updates
6.2 PeproTech
6.2.1 PeproTech Company Information
6.2.2 PeproTech Description and Business Overview
6.2.3 PeproTech GMP Cytokines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 PeproTech GMP Cytokines Product Portfolio
6.2.5 PeproTech Recent Developments/Updates
6.3 CellGenix
6.3.1 CellGenix Company Information
6.3.2 CellGenix Description and Business Overview
6.3.3 CellGenix GMP Cytokines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CellGenix GMP Cytokines Product Portfolio
6.3.5 CellGenix Recent Developments/Updates
6.4 Miltenyi Biotec
6.4.1 Miltenyi Biotec Company Information
6.4.2 Miltenyi Biotec Description and Business Overview
6.4.3 Miltenyi Biotec GMP Cytokines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Miltenyi Biotec GMP Cytokines Product Portfolio
6.4.5 Miltenyi Biotec Recent Developments/Updates
6.5 Cytiva
6.5.1 Cytiva Company Information
6.5.2 Cytiva Description and Business Overview
6.5.3 Cytiva GMP Cytokines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cytiva GMP Cytokines Product Portfolio
6.5.5 Cytiva Recent Developments/Updates
6.6 Lonza
6.6.1 Lonza Company Information
6.6.2 Lonza Description and Business Overview
6.6.3 Lonza GMP Cytokines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Lonza GMP Cytokines Product Portfolio
6.6.5 Lonza Recent Developments/Updates
6.7 ReproCELL
6.7.1 ReproCELL Company Information
6.7.2 ReproCELL Description and Business Overview
6.7.3 ReproCELL GMP Cytokines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ReproCELL GMP Cytokines Product Portfolio
6.7.5 ReproCELL Recent Developments/Updates
6.8 Sino Biological
6.8.1 Sino Biological Company Information
6.8.2 Sino Biological Description and Business Overview
6.8.3 Sino Biological GMP Cytokines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sino Biological GMP Cytokines Product Portfolio
6.8.5 Sino Biological Recent Developments/Updates
6.9 Akron Biotech
6.9.1 Akron Biotech Company Information
6.9.2 Akron Biotech Description and Business Overview
6.9.3 Akron Biotech GMP Cytokines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Akron Biotech GMP Cytokines Product Portfolio
6.9.5 Akron Biotech Recent Developments/Updates
6.10 Creative Bioarray
6.10.1 Creative Bioarray Company Information
6.10.2 Creative Bioarray Description and Business Overview
6.10.3 Creative Bioarray GMP Cytokines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Creative Bioarray GMP Cytokines Product Portfolio
6.10.5 Creative Bioarray Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GMP Cytokines Industry Chain Analysis
7.2 GMP Cytokines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GMP Cytokines Production Mode & Process Analysis
7.4 GMP Cytokines Sales and Marketing
7.4.1 GMP Cytokines Sales Channels
7.4.2 GMP Cytokines Distributors
7.5 GMP Cytokines Customer Analysis
8 GMP Cytokines Market Dynamics
8.1 GMP Cytokines Industry Trends
8.2 GMP Cytokines Market Drivers
8.3 GMP Cytokines Market Challenges
8.4 GMP Cytokines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global GMP Cytokines Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global GMP Cytokines Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global GMP Cytokines Market Competitive Situation by Manufacturers in 2025
 Table 4. Global GMP Cytokines Sales (mg) of Key Manufacturers (2021–2026)
 Table 5. Global GMP Cytokines Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global GMP Cytokines Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global GMP Cytokines Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market GMP Cytokines Average Price (USD/µg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of GMP Cytokines, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of GMP Cytokines, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of GMP Cytokines, Product Types and Applications
 Table 12. Global Key Manufacturers of GMP Cytokines, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GMP Cytokines Companies by Tier (Tier 1, Tier 2, Tier 3), based on GMP Cytokines Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GMP Cytokines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global GMP Cytokines Sales by Region (mg), 2021–2026
 Table 18. Global GMP Cytokines Sales Market Share by Region (2021–2026)
 Table 19. Global GMP Cytokines Sales by Region (mg), 2027–2032
 Table 20. Global GMP Cytokines Sales Market Share by Region (2027–2032)
 Table 21. Global GMP Cytokines Revenue by Region (US$ Million), 2021–2026
 Table 22. Global GMP Cytokines Revenue Market Share by Region (2021–2026)
 Table 23. Global GMP Cytokines Revenue by Region (US$ Million), 2027–2032
 Table 24. Global GMP Cytokines Revenue Market Share by Region (2027–2032)
 Table 25. North America GMP Cytokines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America GMP Cytokines Sales by Country (mg), 2021–2026
 Table 27. North America GMP Cytokines Sales by Country (mg), 2027–2032
 Table 28. North America GMP Cytokines Revenue by Country (US$ Million), 2021–2026
 Table 29. North America GMP Cytokines Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe GMP Cytokines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe GMP Cytokines Sales by Country (mg), 2021–2026
 Table 32. Europe GMP Cytokines Sales by Country (mg), 2027–2032
 Table 33. Europe GMP Cytokines Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe GMP Cytokines Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific GMP Cytokines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific GMP Cytokines Sales by Region (mg), 2021–2026
 Table 37. Asia Pacific GMP Cytokines Sales by Region (mg), 2027–2032
 Table 38. Asia Pacific GMP Cytokines Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific GMP Cytokines Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America GMP Cytokines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America GMP Cytokines Sales by Country (mg), 2021–2026
 Table 42. Latin America GMP Cytokines Sales by Country (mg), 2027–2032
 Table 43. Latin America GMP Cytokines Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America GMP Cytokines Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa GMP Cytokines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa GMP Cytokines Sales by Country (mg), 2021–2026
 Table 47. Middle East and Africa GMP Cytokines Sales by Country (mg), 2027–2032
 Table 48. Middle East and Africa GMP Cytokines Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa GMP Cytokines Revenue by Country (US$ Million), 2027–2032
 Table 50. Global GMP Cytokines Sales (mg) by Type (2021–2026)
 Table 51. Global GMP Cytokines Sales (mg) by Type (2027–2032)
 Table 52. Global GMP Cytokines Sales Market Share by Type (2021–2026)
 Table 53. Global GMP Cytokines Sales Market Share by Type (2027–2032)
 Table 54. Global GMP Cytokines Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global GMP Cytokines Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global GMP Cytokines Revenue Market Share by Type (2021–2026)
 Table 57. Global GMP Cytokines Revenue Market Share by Type (2027–2032)
 Table 58. Global GMP Cytokines Price (USD/µg) by Type (2021–2026)
 Table 59. Global GMP Cytokines Price (USD/µg) by Type (2027–2032)
 Table 60. Global GMP Cytokines Sales (mg) by Application (2021–2026)
 Table 61. Global GMP Cytokines Sales (mg) by Application (2027–2032)
 Table 62. Global GMP Cytokines Sales Market Share by Application (2021–2026)
 Table 63. Global GMP Cytokines Sales Market Share by Application (2027–2032)
 Table 64. Global GMP Cytokines Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global GMP Cytokines Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global GMP Cytokines Revenue Market Share by Application (2021–2026)
 Table 67. Global GMP Cytokines Revenue Market Share by Application (2027–2032)
 Table 68. Global GMP Cytokines Price (USD/µg) by Application (2021–2026)
 Table 69. Global GMP Cytokines Price (USD/µg) by Application (2027–2032)
 Table 70. Bio-Techne Company Information
 Table 71. Bio-Techne Description and Business Overview
 Table 72. Bio-Techne GMP Cytokines Sales (mg), Revenue (US$ Million), Price (USD/µg), and Gross Margin (2021–2026)
 Table 73. Bio-Techne GMP Cytokines Product
 Table 74. Bio-Techne Recent Developments/Updates
 Table 75. PeproTech Company Information
 Table 76. PeproTech Description and Business Overview
 Table 77. PeproTech GMP Cytokines Sales (mg), Revenue (US$ Million), Price (USD/µg), and Gross Margin (2021–2026)
 Table 78. PeproTech GMP Cytokines Product
 Table 79. PeproTech Recent Developments/Updates
 Table 80. CellGenix Company Information
 Table 81. CellGenix Description and Business Overview
 Table 82. CellGenix GMP Cytokines Sales (mg), Revenue (US$ Million), Price (USD/µg), and Gross Margin (2021–2026)
 Table 83. CellGenix GMP Cytokines Product
 Table 84. CellGenix Recent Developments/Updates
 Table 85. Miltenyi Biotec Company Information
 Table 86. Miltenyi Biotec Description and Business Overview
 Table 87. Miltenyi Biotec GMP Cytokines Sales (mg), Revenue (US$ Million), Price (USD/µg), and Gross Margin (2021–2026)
 Table 88. Miltenyi Biotec GMP Cytokines Product
 Table 89. Miltenyi Biotec Recent Developments/Updates
 Table 90. Cytiva Company Information
 Table 91. Cytiva Description and Business Overview
 Table 92. Cytiva GMP Cytokines Sales (mg), Revenue (US$ Million), Price (USD/µg), and Gross Margin (2021–2026)
 Table 93. Cytiva GMP Cytokines Product
 Table 94. Cytiva Recent Developments/Updates
 Table 95. Lonza Company Information
 Table 96. Lonza Description and Business Overview
 Table 97. Lonza GMP Cytokines Sales (mg), Revenue (US$ Million), Price (USD/µg), and Gross Margin (2021–2026)
 Table 98. Lonza GMP Cytokines Product
 Table 99. Lonza Recent Developments/Updates
 Table 100. ReproCELL Company Information
 Table 101. ReproCELL Description and Business Overview
 Table 102. ReproCELL GMP Cytokines Sales (mg), Revenue (US$ Million), Price (USD/µg), and Gross Margin (2021–2026)
 Table 103. ReproCELL GMP Cytokines Product
 Table 104. ReproCELL Recent Developments/Updates
 Table 105. Sino Biological Company Information
 Table 106. Sino Biological Description and Business Overview
 Table 107. Sino Biological GMP Cytokines Sales (mg), Revenue (US$ Million), Price (USD/µg), and Gross Margin (2021–2026)
 Table 108. Sino Biological GMP Cytokines Product
 Table 109. Sino Biological Recent Developments/Updates
 Table 110. Akron Biotech Company Information
 Table 111. Akron Biotech Description and Business Overview
 Table 112. Akron Biotech GMP Cytokines Sales (mg), Revenue (US$ Million), Price (USD/µg), and Gross Margin (2021–2026)
 Table 113. Akron Biotech GMP Cytokines Product
 Table 114. Akron Biotech Recent Developments/Updates
 Table 115. Creative Bioarray Company Information
 Table 116. Creative Bioarray Description and Business Overview
 Table 117. Creative Bioarray GMP Cytokines Sales (mg), Revenue (US$ Million), Price (USD/µg), and Gross Margin (2021–2026)
 Table 118. Creative Bioarray GMP Cytokines Product
 Table 119. Creative Bioarray Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. GMP Cytokines Distributors List
 Table 123. GMP Cytokines Customers List
 Table 124. GMP Cytokines Market Trends
 Table 125. GMP Cytokines Market Drivers
 Table 126. GMP Cytokines Market Challenges
 Table 127. GMP Cytokines Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GMP Cytokines
 Figure 2. Global GMP Cytokines Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global GMP Cytokines Market Share by Type: 2025 & 2032
 Figure 4. TNF Product Picture
 Figure 5. Interleukin Product Picture
 Figure 6. Growth Factor Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global GMP Cytokines Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global GMP Cytokines Market Share by Application: 2025 & 2032
 Figure 10. Cell/Gene Therapy
 Figure 11. Tissue-Engineered Products
 Figure 12. Others
 Figure 13. Global GMP Cytokines Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global GMP Cytokines Market Size (US$ Million), 2021–2032
 Figure 15. Global GMP Cytokines Sales (mg), 2021–2032
 Figure 16. Global GMP Cytokines Average Price (USD/µg), 2021–2032
 Figure 17. GMP Cytokines Report Years Considered
 Figure 18. GMP Cytokines Sales Share by Manufacturers in 2025
 Figure 19. Global GMP Cytokines Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global GMP Cytokines Players: Market Share by Revenue in GMP Cytokines in 2025
 Figure 21. GMP Cytokines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global GMP Cytokines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America GMP Cytokines Sales Market Share by Country (2021–2032)
 Figure 24. North America GMP Cytokines Revenue Market Share by Country (2021–2032)
 Figure 25. U.S. GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe GMP Cytokines Sales Market Share by Country (2021–2032)
 Figure 28. Europe GMP Cytokines Revenue Market Share by Country (2021–2032)
 Figure 29. Germany GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific GMP Cytokines Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific GMP Cytokines Revenue Market Share by Region (2021–2032)
 Figure 36. China GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Taiwan GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Indonesia GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Thailand GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Malaysia GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Philippines GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America GMP Cytokines Sales Market Share by Country (2021–2032)
 Figure 47. Latin America GMP Cytokines Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa GMP Cytokines Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa GMP Cytokines Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. UAE GMP Cytokines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of GMP Cytokines by Type (2021–2032)
 Figure 57. Global Revenue Market Share of GMP Cytokines by Type (2021–2032)
 Figure 58. Global GMP Cytokines Price (USD/µg) by Type (2021–2032)
 Figure 59. Global Sales Market Share of GMP Cytokines by Application (2021–2032)
 Figure 60. Global Revenue Market Share of GMP Cytokines by Application (2021–2032)
 Figure 61. Global GMP Cytokines Price (USD/µg) by Application (2021–2032)
 Figure 62. GMP Cytokines Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String